ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer

Ying Mei; Qinglei Hang; Hongqi Teng; Fan Yao; Mei Kuang Chen; Mien Chie Hung; Yutong Sun; Li Ma

doi:10.1016/j.gendis.2022.09.013

ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer

Ying Mei, Qinglei Hang, Hongqi Teng, Fan Yao, Mei Kuang Chen, Mien Chie Hung, Yutong Sun, Li Ma

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1739-1742
Number of pages	4
Journal	Genes and Diseases
Volume	10
Issue number	5
DOIs	https://doi.org/10.1016/j.gendis.2022.09.013
State	Published - Sep 2023

ASJC Scopus subject areas

Biochemistry
Molecular Biology
Genetics(clinical)
Cell Biology

Access to Document

10.1016/j.gendis.2022.09.013

Cite this

@article{053d894e47d5433b9a9e1b6b60585ceb,

title = "ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer",

author = "Ying Mei and Qinglei Hang and Hongqi Teng and Fan Yao and Chen, {Mei Kuang} and Hung, {Mien Chie} and Yutong Sun and Li Ma",

note = "Funding Information: L.M. is supported by a US National Institutes of Health (NIH) grant R01CA166051 and a Cancer Prevention and Research Institute of Texas (CPRIT) grant RP190029. M.-C.H. was supported by the Sister Institution Fund of MD Anderson Cancer Center and China Medical University. The cores are supported by MD Anderson's Cancer Center Support Grant (CCSG, No. P30CA016672) from NIH. ",

year = "2023",

month = sep,

doi = "10.1016/j.gendis.2022.09.013",

language = "English (US)",

volume = "10",

pages = "1739--1742",

journal = "Genes and Diseases",

issn = "2352-4820",

publisher = "Elsevier BV",

number = "5",

}

TY - JOUR

T1 - ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer

AU - Mei, Ying

AU - Hang, Qinglei

AU - Teng, Hongqi

AU - Yao, Fan

AU - Chen, Mei Kuang

AU - Hung, Mien Chie

AU - Sun, Yutong

AU - Ma, Li

N1 - Funding Information: L.M. is supported by a US National Institutes of Health (NIH) grant R01CA166051 and a Cancer Prevention and Research Institute of Texas (CPRIT) grant RP190029. M.-C.H. was supported by the Sister Institution Fund of MD Anderson Cancer Center and China Medical University. The cores are supported by MD Anderson's Cancer Center Support Grant (CCSG, No. P30CA016672) from NIH.

PY - 2023/9

Y1 - 2023/9

UR - http://www.scopus.com/inward/record.url?scp=85140956103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85140956103&partnerID=8YFLogxK

U2 - 10.1016/j.gendis.2022.09.013

DO - 10.1016/j.gendis.2022.09.013

M3 - Article

C2 - 37492703

AN - SCOPUS:85140956103

SN - 2352-4820

VL - 10

SP - 1739

EP - 1742

JO - Genes and Diseases

JF - Genes and Diseases

IS - 5

ER -

ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this